
Xiaoban Xin
Professional Bio
With years of experience as a biomedical researcher, Dr. Xiaoban Xin assists companies and research institutes with building, managing, and protecting their patent assets, strategic patent counseling, and due diligence. Xiaoban has specific experience working with clients in the fields of biotechnology, including gene editing (e.g., CRISPR technology), next generation sequencing, immunotherapy, cell therapy, biologics, stem cells, genetically modified animals, and pharmaceutical formulations, as well as medical device and health IT.
Patent Term Extension Introduced by the Fourth Amendment to the Chinese Patent Law
Biosimilars Law Bulletin ·
Growing Competition for the World’s Most Profitable Drug as Multiple New Adalimumab Biosimilars Launch
Biosimilars Law Bulletin ·
When Do My Patents Expire?
RF EMerge ·
7th Circuit Hears Oral Arguments in Humira “Patent Thicket” Antitrust Case
Biosimilars Law Bulletin ·